How did insulin become unaffordable for millions of Americans and what can policymakers do about it?
Altarum's new report, Strategies to Advance Insulin Affordability in the United States, answers this question and provides a detailed set of policy proposals to make insulins affordable to patients and payers through federal regulation, market reforms, and direct government action.
Altarum economist Ani Turner co-authored the report with Dr. Rena Conti of Boston University, a nationally recognized economist and expert on drug pricing, and Altarum economist Paul Hughes-Cromwick. The report was funded by the National Institute for Health Care Reform, a nonprofit health care policy research organization established by the International Union, UAW; Chrysler Group; Ford Motor Company; and General Motors.
Download the report, Strategies to Advance Insulin Affordability in the United States, and read the press release.